Immunotherapy for Renal Cell Carcinoma-What More is to Come?
Saved in:
| Title: | Immunotherapy for Renal Cell Carcinoma-What More is to Come? |
|---|---|
| Authors: | Yochum ZA; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Center of Molecular and Cellular Oncology, Yale Cancer Center, New Haven, CT, USA., Braun DA; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu.; Center of Molecular and Cellular Oncology, Yale Cancer Center, New Haven, CT, USA. david.braun@yale.edu.; Department of Pathology, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu.; Department of Urology, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu. |
| Source: | Targeted oncology [Target Oncol] 2025 May; Vol. 20 (3), pp. 467-483. Date of Electronic Publication: 2025 Apr 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1776-260X |
|---|---|
| DOI: | 10.1007/s11523-025-01143-7 |
